Cencora (LTS:0HF3) Cyclically Adjusted Revenue per Share: $1,258.33 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0HF3 Cencora Inc LTS:0HF3
79 GF Score
Price $312.16
GF Value $290.54
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Cencora Cyclically Adjusted Revenue per Share?

Cencora LTS:0HF3 -0.42% 79 Cyclically Adjusted Revenue per Share is $1,258.33 as of Mar. 2026. GuruFocus rates LTS:0HF3 with a GF Score™ of 79/100 and a GF Value™ of $290.54 (Fairly Valued). The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Cencora's adjusted revenue per share for the three months ended in Mar. 2026 was $401.038. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $1,258.33 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Cencora's average Cyclically Adjusted Revenue Growth Rate was 10.50% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 11.30% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 13.80% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 14.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Cencora was 16.90% per year. The lowest was 11.30% per year. And the median was 14.90% per year.

As of today (2026-08-03), Cencora's current stock price is $312.16. Cencora's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was $1,258.33. Cencora's Cyclically Adjusted PS Ratio of today is 0.25.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Cencora was 0.30. The lowest was 0.14. And the median was 0.19.


Cencora  (LTS:0HF3) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Cencora's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=312.16/1258.33
=0.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Cencora was 0.30. The lowest was 0.14. And the median was 0.19.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Cencora Cyclically Adjusted Revenue per Share Related Terms


Cencora Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Cencora's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cencora Cyclically Adjusted Revenue per Share Chart

Cencora Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 763.04 881.47 992.56 1,090.48 1,202.46

Cencora Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,145.78 1,188.59 1,202.46 1,238.94 1,258.33

LTS:0HF3 vs CAH, MCK, HSIC: Cyclically Adjusted Revenue per Share Comparison

For the Medical Distribution subindustry, Cencora's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cencora Cyclically Adjusted PS Ratio vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Cencora's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Cencora's Cyclically Adjusted PS Ratio falls into.


LTS:0HF3
79GF Score
Cencora Inc LTS:0HF3
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cencora Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Cencora's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=401.038/330.2130*330.2130
=401.038

Current CPI (Mar. 2026) = 330.2130.

Cencora Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 164.063 241.018 224.779
201609 165.540 241.428 226.417
201612 171.950 241.432 235.181
201703 167.920 243.801 227.437
201706 174.456 244.955 235.176
201709 176.762 246.819 236.485
201712 183.253 246.524 245.463
201803 184.585 249.554 244.245
201806 195.426 251.989 256.091
201809 199.110 252.439 260.454
201812 212.145 251.233 278.837
201903 203.797 254.202 264.736
201906 214.241 256.143 276.194
201909 213.353 256.759 274.389
201912 230.655 256.974 296.393
202003 229.002 258.115 292.968
202006 220.716 257.797 282.716
202009 241.300 260.280 306.133
202012 253.947 260.474 321.938
202103 237.099 264.877 295.583
202106 255.637 271.696 310.695
202109 279.440 274.310 336.388
202112 282.376 278.802 334.446
202203 272.273 287.504 312.719
202206 283.674 296.311 316.130
202209 291.387 296.808 324.182
202212 304.598 296.797 338.892
202303 310.675 301.836 339.883
202306 327.570 305.109 354.522
202309 338.886 307.789 363.576
202312 357.976 306.746 385.362
202403 340.070 312.332 359.539
202406 371.120 314.175 390.065
202409 399.120 315.301 417.996
202412 417.480 315.605 436.803
202503 386.755 319.799 399.349
202506 413.172 322.561 422.974
202509 428.630 324.800 435.773
202512 439.957 324.054 448.319
202603 401.038 330.213 401.038

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of $1,258.33 mean?
Cencora (LTS:0HF3) has a Cyclically Adjusted Revenue per Share of $1,258.33 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Cencora and its competitors.
Is Cencora's Cyclically Adjusted Revenue per Share too high?
Cencora's current Cyclically Adjusted Revenue per Share is $1,258.33. Overall, Cencora has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cencora's Cyclically Adjusted Revenue per Share compare to CAH and MCK?
Cencora's Cyclically Adjusted Revenue per Share of $1,258.33 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Distribution company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Distribution industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Cencora and its competitors. Cencora's current Cyclically Adjusted Revenue per Share is $1,258.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cencora stock overvalued right now?
Based on GuruFocus' analysis, Cencora (LTS:0HF3) is currently considered Fairly Valued. The stock's GF Value™ is $290.54, compared to a current price of $312.16 — trading 7.4% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is $1,258.33. Cencora's overall GF Score™ is 79/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Cencora (LTS:0HF3), the current Cyclically Adjusted Revenue per Share is $1,258.33 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cencora (LTS:0HF3) Overvalued in 2026?

Based on GuruFocus' analysis, Cencora stock appears to be overvalued. The current stock price of $312.16 is trading 7.4% above its estimated GF Value™ of $290.54. GuruFocus considers Cencora to be Fairly Valued.

Key valuation signals for LTS:0HF3:

  • Cyclically Adjusted Revenue per Share: $1,258.33
  • GF Value™: $290.54 vs. price of $312.16 (7.4% above fair value)
  • GF Score™: 79/100 with 1 warning sign

No single metric tells the full story. See the LTS:0HF3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cencora Business Description

Address 1 West First Avenue, Conshohocken, PA, USA, 19428-1800
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
79GF Score

Get the complete analysis for LTS:0HF3

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$312.16
Price
$290.54
GF Value